Topic

Ohio

A collection of 479 issues

Renewing Pemazyre (Pemigatinib) Approval with UnitedHealthcare in Ohio: Complete 2025 Renewal Guide

Answer Box: Renewing Pemazyre with UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization renewal for Pemazyre (pemigatinib) every 12 months, with approval based on documented clinical response and absence of disease progression. Submit renewal requests 2-4 weeks before your current authorization expires through the UHC provider portal or by calling 866-889-8054.
6 min read

How Long Does It Take to Get Orladeyo (berotralstat) Approved by Blue Cross Blue Shield in Ohio? Complete Timeline & Appeal Guide

Answer Box: Getting Orladeyo Approved by Blue Cross Blue Shield in Ohio Timeline: 1-14 days for standard prior authorization, 24-72 hours for urgent cases. Blue Cross Blue Shield Ohio (primarily Anthem) requires prior authorization for Orladeyo (berotralstat) with specialist documentation of hereditary angioedema diagnosis, C1-INH testing, and often step therapy
6 min read

Getting Tecentriq (Atezolizumab) Approved by UnitedHealthcare in Ohio: Complete PA Guide

Answer Box: Fast Track to Tecentriq Approval UnitedHealthcare requires prior authorization for Tecentriq (atezolizumab) in Ohio through their provider portal at UHCprovider.com. Submit PA requests with complete clinical documentation including PD-L1 testing, staging, and FDA-approved indication alignment. First step today: Have your oncologist gather pathology reports, biomarker results, and
6 min read